These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

709 related articles for article (PubMed ID: 17610276)

  • 21. Suppressed bone turnover during alendronate therapy for high-turnover osteoporosis.
    Armamento-Villareal R; Napoli N; Panwar V; Novack D
    N Engl J Med; 2006 Nov; 355(19):2048-50. PubMed ID: 17093260
    [No Abstract]   [Full Text] [Related]  

  • 22. Osteoporosis. Efficacy and safety of a bisphosphonate dosed once weekly.
    Baran D
    Geriatrics; 2001 Mar; 56(3):28-32. PubMed ID: 11252758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bisphosphonate treatment affects trabecular bone apparent modulus through micro-architecture rather than matrix properties.
    Day JS; Ding M; Bednarz P; van der Linden JC; Mashiba T; Hirano T; Johnston CC; Burr DB; Hvid I; Sumner DR; Weinans H
    J Orthop Res; 2004 May; 22(3):465-71. PubMed ID: 15099622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bone histomorphometry;A role of evaluation for bone quality and mechanical strength].
    Yamamoto N; Takahashi H; Shimakura T
    Clin Calcium; 2016 Jan; 26(1):9-15. PubMed ID: 26728526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
    McComsey GA; Kendall MA; Tebas P; Swindells S; Hogg E; Alston-Smith B; Suckow C; Gopalakrishnan G; Benson C; Wohl DA
    AIDS; 2007 Nov; 21(18):2473-82. PubMed ID: 18025884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Skeletal actions of intermittent parathyroid hormone: effects on bone remodelling and structure.
    Compston JE
    Bone; 2007 Jun; 40(6):1447-52. PubMed ID: 17045858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84.
    Recker RR; Bare SP; Smith SY; Varela A; Miller MA; Morris SA; Fox J
    Bone; 2009 Jan; 44(1):113-9. PubMed ID: 18983947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Assessment of bone quality. Bone quality and osteoporosis treatment].
    Mashiba T
    Clin Calcium; 2008 Mar; 18(3):300-7. PubMed ID: 18310816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic antiosteoporotic effect of Lepidium sativum and alendronate in glucocorticoid-induced osteoporosis in Wistar rats.
    Elshal MF; Almalki AL; Hussein HK; Khan JA
    Afr J Tradit Complement Altern Med; 2013; 10(5):267-73. PubMed ID: 24311835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alendronate prevents development of the skeletal changes induced by azathioprine in rats.
    Cegieła U; Kaczmarczyk-Sedlak I; Pytlik M; Folwarczna J; Nowińska B; Fronczek-Sokół J
    Acta Pol Pharm; 2013; 70(2):309-15. PubMed ID: 23614287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiosteoporotic effect of Polycan, beta-glucan from Aureobasidium, in ovariectomized osteoporotic mice.
    Shin HD; Yang KJ; Park BR; Son CW; Jang HJ; Ku SK
    Nutrition; 2007; 23(11-12):853-60. PubMed ID: 17884343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of the systemic administration of alendronate on bone formation in a porous hydroxyapatite/collagen composite and resorption by osteoclasts in a bone defect model in rabbits.
    Sugata Y; Sotome S; Yuasa M; Hirano M; Shinomiya K; Okawa A
    J Bone Joint Surg Br; 2011 Apr; 93(4):510-6. PubMed ID: 21464492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteotropic Peptide that differentiates functional domains of the skeleton.
    Wang D; Miller SC; Shlyakhtenko LS; Portillo AM; Liu XM; Papangkorn K; Kopecková P; Lyubchenko Y; Higuchi WI; Kopecek J
    Bioconjug Chem; 2007; 18(5):1375-8. PubMed ID: 17705416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adaptation of cancellous bone to aging and immobilization in the rat: a single photon absorptiometry and histomorphometry study.
    Li XJ; Jee WS; Chow SY; Woodbury DM
    Anat Rec; 1990 May; 227(1):12-24. PubMed ID: 2195916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of bisphosphonate treatment on bone mineral density in patients with thalassaemia major.
    Skordis N; Ioannou YS; Kyriakou A; Savva SC; Efstathiou E; Savvides I; Christou S
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():144-8. PubMed ID: 19337169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Parathyroid and bone. Evidence and perspective of parathyroid therapy for patients with osteoporosis].
    Wada S; Fukawa T; Kamiya S
    Clin Calcium; 2007 Dec; 17(12):1888-94. PubMed ID: 18057665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological effects of tiludronate in horses after long-term immobilization.
    Delguste C; Amory H; Doucet M; Piccot-Crézollet C; Thibaud D; Garnero P; Detilleux J; Lepage OM
    Bone; 2007 Sep; 41(3):414-21. PubMed ID: 17604709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Assessment of bone quality. Bone remodeling and bone quality].
    Sano G; Matsuo K
    Clin Calcium; 2008 Mar; 18(3):315-20. PubMed ID: 18310818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo rat assay: bone remodeling and steroid effects on juvenile bone by pQCT quantification in 7 days.
    McHugh NA; Vercesi HM; Egan RW; Hey JA
    Am J Physiol Endocrinol Metab; 2003 Jan; 284(1):E70-5. PubMed ID: 12388153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiremodeling agents influence osteoblast activity differently in modeling and remodeling sites of canine rib.
    Allen MR; Follet H; Khurana M; Sato M; Burr DB
    Calcif Tissue Int; 2006 Oct; 79(4):255-61. PubMed ID: 17033724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.